UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 93

Sortiert nach

The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis

European journal of immunology, 2018-11, Vol.48 (11), p.1861-1871

2018

Link zum Volltext

Verfügbarkeit prüfen

Serum hepcidin: reference ranges and biochemical correlates in the general population

Blood, 2011-06, Vol.117 (25), p.e218-e225

2011

Link zum Volltext

Verfügbarkeit prüfen

Immunochemical and Mass-Spectrometry-Based Serum Hepcidin Assays for Iron Metabolism Disorders

Clinical chemistry (Baltimore, Md.), 2010-10, Vol.56 (10), p.1570-1579

2010

Link zum Volltext

Verfügbarkeit prüfen

HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients

Tumor biology, 2018-02, Vol.40 (2), p.1010428318757103-1010428318757103

2018

Link zum Volltext

Verfügbarkeit prüfen

Mucosal lactoferrin response to genital tract infections is associated with iron and nutritional biomarkers in young Burkinabé women

European journal of clinical nutrition, 2019-11, Vol.73 (11), p.1464-1472

2019

Link zum Volltext

Verfügbarkeit prüfen

Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials

The Lancet. Haematology, 2017-11, Vol.4 (11), p.e524-e533

2017

Link zum Volltext

Verfügbarkeit prüfen

Meta-GWAS and Meta-Analysis of Exome Array Studies Do Not Reveal Genetic Determinants of Serum Hepcidin

PloS one, 2016-11, Vol.11 (11), p.e0166628-e0166628

2016

Link zum Volltext

Verfügbarkeit prüfen

High‐sensitive radioimmunoassay for human serum hepcidin

British journal of haematology, 2009-08, Vol.146 (3), p.317-325

2009

Link zum Volltext

Verfügbarkeit prüfen

Donation intensity and metabolic syndrome in active whole-blood donors

Vox sanguinis, 2015-07, Vol.109 (1), p.25-34

2015

Link zum Volltext

Verfügbarkeit prüfen

Quantification of patient-specific assay interference in different formats of enzyme-linked immunoassays for therapeutic monoclonal antibodies

Therapeutic drug monitoring, 2014-12, Vol.36 (6), p.765

2014

Link zum Volltext

Verfügbarkeit prüfen

Malaria early in the first pregnancy: Potential impact of iron status

Clinical nutrition (Edinburgh, Scotland), 2020-01, Vol.39 (1), p.204-214

2020

Link zum Volltext

Verfügbarkeit prüfen

The donation interval of 56 days requires extension to 180 days for whole blood donors to recover from changes in iron metabolism

Blood, 2016-10, Vol.128 (17), p.2185-2188

2016

Link zum Volltext

Verfügbarkeit prüfen

Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material

Clinical chemistry (Baltimore, Md.), 2016-07, Vol.62 (7), p.993-1001

2016

Link zum Volltext

Verfügbarkeit prüfen

Maternal soluble fms-like tyrosine kinase-1, placental growth factor, plasminogen activator inhibitor-2, and folate concentrations and early fetal size: the Generation R study

American journal of obstetrics and gynecology, 2013-08, Vol.209 (2), p.121.e1-121.e11

2013

Link zum Volltext

Verfügbarkeit prüfen

Effects of Weekly Iron and Folic Acid Supplements on Malaria Risk in Nulliparous Women in Burkina Faso: A Periconceptional, Double-Blind, Randomized Controlled Noninferiority Trial

The Journal of infectious diseases, 2018-08, Vol.218 (7), p.1099-1109

2018

Link zum Volltext

Verfügbarkeit prüfen

Angiogenic and Fibrinolytic Factors in Blood During the First Half of Pregnancy and Adverse Pregnancy Outcomes

Obstetrics and gynecology (New York. 1953), 2012-06, Vol.119 (6), p.1190-1200

2012

Link zum Volltext

Verfügbarkeit prüfen

Associations of common variants in HFE and TMPRSS6 with iron parameters are independent of serum hepcidin in a general population: a replication study

Journal of medical genetics, 2013-09, Vol.50 (9), p.593-598

2013

Link zum Volltext

Verfügbarkeit prüfen

Screening for interference in immunoassays

Clinical chemistry (Baltimore, Md.), 2003-10, Vol.49 (10), p.1708-1709

2003

Link zum Volltext

Verfügbarkeit prüfen

The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer

Thrombosis and haemostasis, 2004-03, Vol.91 (3), p.514

2004

Link zum Volltext

Verfügbarkeit prüfen

Plasminogen activators are involved in angiostatin generation in vivo in benign and malignant ovarian tumor cyst fluids

International journal of oncology, 2014-04, Vol.44 (4), p.1394-1400

2014

Link zum Volltext

Verfügbarkeit prüfen

The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy

British journal of cancer, 2002-09, Vol.87 (7), p.772-778

2002

Link zum Volltext

Verfügbarkeit prüfen

Engineered human lipocalin as an antibody mimetic: application to analysis of the small peptide hormone hepcidin

Clinical chemistry (Baltimore, Md.), 2014-06, Vol.60 (6), p.897-899

2014

Link zum Volltext

Verfügbarkeit prüfen

Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer

Biological chemistry, 2010-04, Vol.391 (4), p.391-401

2010

Link zum Volltext

Verfügbarkeit prüfen

External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts

British journal of cancer, 1998-12, Vol.78 (11), p.1434-1441

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(80)

Publikationsform

Artikel
(93)

Sprache

Englisch
(93)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The macrophage migration inhibitory factor pathway in human B cells is tightly controlled and dysregulated in multiple sclerosis

Serum hepcidin: reference ranges and biochemical correlates in the general population

Immunochemical and Mass-Spectrometry-Based Serum Hepcidin Assays for Iron Metabolism Disorders

HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients

Mucosal lactoferrin response to genital tract infections is associated with iron and nutritional biomarkers in young Burkinabé women

Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials

Meta-GWAS and Meta-Analysis of Exome Array Studies Do Not Reveal Genetic Determinants of Serum Hepcidin

High‐sensitive radioimmunoassay for human serum hepcidin

Donation intensity and metabolic syndrome in active whole-blood donors

Quantification of patient-specific assay interference in different formats of enzyme-linked immunoassays for therapeutic monoclonal antibodies

Malaria early in the first pregnancy: Potential impact of iron status

The donation interval of 56 days requires extension to 180 days for whole blood donors to recover from changes in iron metabolism

Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material

Maternal soluble fms-like tyrosine kinase-1, placental growth factor, plasminogen activator inhibitor-2, and folate concentrations and early fetal size: the Generation R study

Effects of Weekly Iron and Folic Acid Supplements on Malaria Risk in Nulliparous Women in Burkina Faso: A Periconceptional, Double-Blind, Randomized Controlled Noninferiority Trial

Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material

Angiogenic and Fibrinolytic Factors in Blood During the First Half of Pregnancy and Adverse Pregnancy Outcomes

Associations of common variants in HFE and TMPRSS6 with iron parameters are independent of serum hepcidin in a general population: a replication study

Screening for interference in immunoassays

The complex between urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-I) independently predicts response to first-line endocrine therapy in advanced breast cancer

Plasminogen activators are involved in angiostatin generation in vivo in benign and malignant ovarian tumor cyst fluids

The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy

Engineered human lipocalin as an antibody mimetic: application to analysis of the small peptide hormone hepcidin

Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer

External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 inhibitor (PAI-1) in human breast cancer tissue extracts

Suchergebnisse filtern